BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, March 1, 2025
See today's BioWorld
Home
» Macro Woes Could Impact Biotech Financing, M&A
To read the full story,
subscribe
or
sign in
.
Macro Woes Could Impact Biotech Financing, M&A
Aug. 22, 2011
By
Trista Morrison
No Comments
The economic situation over the last month or so "reminds a lot of people of 2008 and I can understand why," said Andy Busch, global currency and public policy strategist for BMO Capital Markets, during a recent conference call.
BioWorld